WithdrawnPhase 1ACTRN12607000223437

A SINGLE CENTER OPEN-LABEL PILOT STUDY TO EVALUATE THE TOLERABILITY AND SAFETY OF A SYNTHETIC SOFT TISSUE IMPLANT MATERIAL IN THE SKIN OF NORMAL VOLUNTEERS

A single centre open-label pilot study to evaluate the tolerability and safety of the Family C synthetic thermoplastic block copolymer implant as a clinically acceptable dermal filler material in healthy volunteers.


Sponsor

COSMETREND PTY LTD

Enrollment

8 participants

Start Date

Jun 1, 2007

Study Type

Interventional

Conditions

Summary

The primary purpose of this pilot study is to assess the clinical tolerability and safety of a new synthetic soft tissue implant material in the skin of healthy volunteers.


Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

This pilot study evaluates whether a new treatment or approach is safe and well-tolerated by patients. This study is open to both men and women aged 18 and older. Participation involves receiving the study treatment with close monitoring for any side effects.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Each participant will receive two (diameter - 4.4 mm, thickness ~1 to 2 mm) Test Article implants, placed at the mid-to-deep dermal layer and/or superficial fat junction of their skin. The implant si

Each participant will receive two (diameter - 4.4 mm, thickness ~1 to 2 mm) Test Article implants, placed at the mid-to-deep dermal layer and/or superficial fat junction of their skin. The implant sites will be selected by the investigator within the anatomic region of the torso (superior pelvic rim to the apex of the shoulders) of each participant. The skin implant material will be placed by making a small single incision, up to 1.5 cm in length to the level of the mid-to-deep dermis or superficial fat junction, as appropriate. The implant will then be placed into the incision pocket and sutured closed. The implants will remain in place for 90 days with follow up visits at days 7, 14, 30, 60 for evaluation and grading of site per protocol. At day 90 the implants will be excised. All specimens will be submitted for histologic examination. A final visit will occur 30 days post excision for evaluation of the test sites.


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12607000223437